MDTMedtronic plc

NYSE medtronic.com


$ 81.61 $ 1.47 (1.83 %)    

Friday, 21-Jun-2024 15:59:51 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 81.64
$ 80.11
$ 0.00 x 0
$ 0.00 x 0
$ 79.96 - $ 81.69
$ 67.71 - $ 88.75
11,096,007
na
104.68B
$ 0.93
$ 28.48
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-20-2024 04-26-2024 10-K
2 02-27-2024 01-26-2024 10-Q
3 11-30-2023 10-27-2023 10-Q
4 08-31-2023 07-28-2023 10-Q
5 06-22-2023 04-28-2023 10-K
6 03-01-2023 01-27-2023 10-Q
7 12-01-2022 10-28-2022 10-Q
8 09-01-2022 07-29-2022 10-Q
9 06-23-2022 04-29-2022 10-K
10 03-03-2022 01-28-2022 10-Q
11 12-02-2021 10-29-2021 10-Q
12 09-02-2021 07-30-2021 10-Q
13 06-25-2021 04-30-2021 10-K
14 03-05-2021 01-29-2021 10-Q
15 12-03-2020 10-30-2020 10-Q
16 09-03-2020 07-31-2020 10-Q
17 06-19-2020 04-24-2020 10-K
18 02-28-2020 01-24-2020 10-Q
19 12-03-2019 10-25-2019 10-Q
20 08-30-2019 07-26-2019 10-Q
21 06-21-2019 04-26-2019 10-K
22 03-01-2019 01-25-2019 10-Q
23 11-29-2018 10-26-2018 10-Q
24 08-31-2018 07-27-2018 10-Q
25 06-22-2018 04-27-2018 10-K
26 03-02-2018 01-26-2018 10-Q
27 12-04-2017 10-27-2017 10-Q
28 09-01-2017 07-28-2017 10-Q
29 06-27-2017 04-28-2017 10-K
30 03-03-2017 01-27-2017 10-Q
31 12-05-2016 10-28-2016 10-Q
32 09-07-2016 07-29-2016 10-Q
33 06-28-2016 04-29-2016 10-K
34 03-09-2016 01-29-2016 10-Q
35 12-09-2015 10-30-2015 10-Q
36 09-09-2015 07-31-2015 10-Q
37 06-23-2015 04-24-2015 10-K
38 02-27-2015 01-23-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-medtronics-minimed-780g-shows-data-on-hyperglycemia-and-nighttime-relief

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the Ameri...

 medtronic-recalls-some-versions-of-software-used-for-cranial-surgery

Medtronic is recalling specific StealthStation S8 application versions due to a serious software error affecting surgical navig...

 fda-says-medtronic-reports-28-complaints-related-to-stealthstation-s8-application-issue-medtronic-recalled-certain-stealthstation-s8-application-versions-for-software-error-that-may-cause-incorrect-measurements-during-cranial-surgery

- Reuters

 rbc-capital-reiterates-sector-perform-on-medtronic-maintains-92-price-target

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.

 goldman-sachs-initiates-coverage-on-medtronic-with-sell-rating-announces-price-target-of-83

Goldman Sachs analyst David Roman initiates coverage on Medtronic (NYSE:MDT) with a Sell rating and announces Price Target o...

 medtronic-subsidiary-prices-senior-notes-offering

Medtronic, Inc., has priced an offering of €850 million of 3.650% senior notes due 2029, €850 million of 3.875% senior notes du...

 wells-fargo-maintains-overweight-on-medtronic-raises-price-target-to-105

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $102 t...

 rbc-capital-reiterates-sector-perform-on-medtronic-maintains-92-price-target

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.

 ubs-maintains-sell-on-medtronic-raises-price-target-to-76

UBS analyst Matthew Taylor maintains Medtronic (NYSE:MDT) with a Sell and raises the price target from $75 to $76.

 truist-securities-maintains-hold-on-medtronic-lowers-price-target-to-88

Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and lowers the price target from $90 t...

 needham-reiterates-hold-on-medtronic

Needham analyst Mike Matson reiterates Medtronic (NYSE:MDT) with a Hold.

 nvidias-10-leap-propels-tech-indexes-to-record-highs-blue-chips-small-caps-slip-whats-driving-markets-thursday

Strong earnings and revenue guidance from Nvidia sparked a tech stock surge, with Nasdaq 100 and S&P 500 hitting record highs.

 medtronics-q4-earnings-medical-device-giant-clocks-strong-sales-from-neurology-devices-hikes-dividend

Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0...

 wall-street-braces-for-strong-open-on-nvidia-cheer-but-traders-wary-of-key-data-why-this-analyst-sees-more-market-bullishness-near-term

Major U.S.